ctDNA Predicts Pain Response in a Multi-Institutional Phase II Trial of Palliative Radiation, Palbociclib and Hormone Therapy in Metastatic Breast Cancer

被引：0
|
作者：
Torres, M. [1 ]
Friend, S. [2 ]
Niemierko, A. [3 ]
Lin, J. Y. [1 ]
Iafrate, A. [3 ]
Xiao, C. [4 ]
Kahn, S. T. [5 ]
Godette, K. D. [6 ]
Hanasoge, S. [5 ]
Yu, D. S. [6 ]
Eng, T. Y. [5 ]
Cheney, M. D. [7 ]
Wiggers, N. [8 ]
Pippas, A. [9 ]
Goginini, K.
Meisel, J. [10 ]
Schuster, D. M. [11 ]
Bardia, A. [12 ]
Miller, A. H. [13 ]
Felger, J.
Switchenko, J. [14 ]
Zelnak, A. [15 ]
Kalinsky, K. [16 ]
Daniels, T. [2 ]
Medford, A. [3 ]
Bhave, M. [17 ]
机构：
[1] Emory Univ, Glenn Family Breast Ctr, Winship Canc Inst, Atlanta, GA USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA USA
[5] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA USA
[6] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA
[7] Spectrum Healthcare Partners, Portland, ME USA
[8] Northside Hosp, Atlanta, GA USA
[9] Piedmont Columbus Reg, John B. Amos Canc Ctr, Columbus, GA USA
[10] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA USA
[11] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA USA
[12] UCLA, Los Angeles, CA USA
[13] Emory Univ, Sch Medi, Dept Psychiat & Behav Sci, Atlanta, GA USA
[14] Emory Univ, Atlanta, GA USA
[15] Northside Hosp, Atlanta Canc Care, Atlanta, GA USA
[16] Emory Winship Canc Inst, Atlanta, GA USA
[17] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1037
引用
收藏
页码：S164 / S164
页数：1
相关论文
共 50 条
  • [21] SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.
    Daneshmand, Siamak
    Cary, Clint
    Masterson, Timothy A.
    Einhorn, Lawrence
    Boorjian, Stephen A.
    Kollmannsberger, Christian K.
    Schuckman, Anne K.
    So, Alan
    Black, Peter C.
    Bagrodia, Aditya
    Skinner, Eila C.
    Alemozaffar, Mehrdad
    Brand, Timothy C.
    Eggener, Scott E.
    Pierorazio, Phillip M.
    Stratton, Kelly Lynn
    Nappi, Lucia
    Nichols, Craig R.
    Hu, Brain
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [22] Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial
    Zanudo, Jorge Gomez Tejeda
    Barroso-Sousa, Romualdo
    Jain, Esha
    Jin, Qingchun
    Li, Tianyu
    Buendia-Buendia, Jorge E.
    Pereslete, Alyssa
    Abravanel, Daniel L.
    Ferreira, Arlindo R.
    Wrabel, Eileen
    Helvie, Karla
    Hughes, Melissa E.
    Partridge, Ann H.
    Overmoyer, Beth
    Lin, Nancy U.
    Tayob, Nabihah
    Tolaney, Sara M.
    Wagle, Nikhil
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [23] A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer
    Kitagawa, Ryo
    Katsumata, Noriyuki
    Ando, Masashi
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Yoshikawa, Hiroyuki
    Satoh, Toyomi
    Nakanishi, Toru
    Ushijima, Kimio
    Kamura, Toshiharu
    GYNECOLOGIC ONCOLOGY, 2012, 125 (02) : 307 - 311
  • [24] Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial
    Jorge Gómez Tejeda Zañudo
    Romualdo Barroso-Sousa
    Esha Jain
    Qingchun Jin
    Tianyu Li
    Jorge E. Buendia-Buendia
    Alyssa Pereslete
    Daniel L. Abravanel
    Arlindo R. Ferreira
    Eileen Wrabel
    Karla Helvie
    Melissa E. Hughes
    Ann H. Partridge
    Beth Overmoyer
    Nancy U. Lin
    Nabihah Tayob
    Sara M. Tolaney
    Nikhil Wagle
    Nature Communications, 15
  • [25] Palliative Radiation Therapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial
    Tey, J.
    Lee, K. M.
    Leong, C. N.
    Zheng, H.
    Koh, W. Y.
    Lim, K. H. C.
    Soon, Y. Y.
    Tham, I.
    Lu, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E134 - E135
  • [26] Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy
    Vo, M. N.
    Evans, M.
    Leitzel, K.
    Ali, S. M.
    Wilson, M.
    Demers, L.
    Evans, D. B.
    Lipton, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (03) : 767 - 771
  • [27] Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy
    M. N. Vo
    M. Evans
    K. Leitzel
    S. M. Ali
    M. Wilson
    L. Demers
    D. B. Evans
    A. Lipton
    Breast Cancer Research and Treatment, 2010, 119 : 767 - 771
  • [28] Evaluation of low-dose fractionated radiation therapy as a chemopotentiator of gemcitabine in advanced pancreatic cancer: results from an international multi-institutional phase II trial
    Sharma, Navesh K.
    Pandya, Naimish B.
    Wong, Raimond K.
    Herman, Joseph M.
    Hanna, Nader N.
    Laheru, Daniel A.
    Major, Pierre P.
    Alexander, H. Richard
    Kennedy, Nancy L.
    Regine, William F.
    JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (04) : 401 - 409
  • [29] A phase II study of pembrolizumab in combination with palliative radiotherapy for metastatic hormone receptor positive breast cancer
    Barroso-Sousa, Romualdo
    Gao, Hao
    Barry, William T.
    Krop, Ian E.
    Schoenfeld, Jonathan D.
    Tolaney, Sara M.
    CANCER RESEARCH, 2018, 78 (04)
  • [30] A multi-institutional, phase I/II trial of dose-per-fraction escalation for prostate cancer
    Ritter, M.
    Forman, J.
    Petereit, D.
    Kupelian, P.
    Wang, D.
    Walker, W.
    Fowler, J.
    Chappell, R.
    Tome, W.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S73 - S73
12345